Towards Healthcare
Immunoassay Market to Reach USD 56.54 Bn by 2034

Immunoassay Market Expansion Fueled by ELISA and Next-Gen Technologies

According to market projections, the immunoassay sector is expected to grow from USD 35.61 billion in 2024 to USD 56.54 billion by 2034, reflecting a CAGR of 4.72%. Ongoing technological advances are propelling the global market growth. North America dominated the market due to a rise in demand for precision diagnostics, treatment, and R&D investments.

Content

  • Last Updated: 16 September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The immunoassay market is worth USD 37.29 billion in 2025, and by 2034, it is forecasted to hit USD 56.54 billion, registering a CAGR of 4.72% over the decade.

North America is currently leading the immunoassay market due to growing R&D investments and focus on precision approaches.

The immunoassay market includes 5 segments such as by product, by technology, by application, by end-user, and by region.

Some key players include Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific, Inc.

The different types of ELISA tests are direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA.

NIH, EPA.GOV, NCI, OJP.GOV, MedlinePlus.gov, OHSU, USGS, NASA.GOV.
Any Questions